{"id":306,"date":"2009-05-15T12:51:17","date_gmt":"2009-05-15T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=306"},"modified":"2018-04-16T13:39:08","modified_gmt":"2018-04-16T18:39:08","slug":"306","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/306\/","title":{"rendered":"2009 \u5e74 5 \u6708 15 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca"},"content":{"rendered":"<p><a href=\"\/wp-content\/uploads\/2018\/01\/AHN_5-15-09.pdf\" target=\"_blank\" rel=\"noopener\">\u6253\u5370\u7248\u672c<\/a><\/p>\n<p>************************************<br \/>\n<strong>Brakke \u54a8\u8be2\u516c\u53f8\u7684<br \/>\n2009 \u5e74 5 \u6708 15 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca<\/strong><br \/>\n\u7248\u6743\u6240\u6709 \u00a9 Brakke \u54a8\u8be2\u516c\u53f8<\/p>\n<p>\u7f16\u8f91\uff1aLynn Fondon\uff0c\u517d\u533b\uff0c\u5de5\u5546\u7ba1\u7406\u7855\u58eb<br \/>\n************************************<br \/>\n\u65b0\u95fb\u62a5\u9053\uff1a<\/p>\n<p><u>\u76c8\u5229\u65b0\u95fb<br \/>\n<\/u>\u963f\u5c14\u6cd5\u739b<br \/>\n\u751f\u5316\u4eba<br \/>\n\u5ba0\u7269\u533b\u7597\u5feb\u9012<br \/>\n\u666e\u4e50\u7ef4\u7f8e<br \/>\n\u96f7\u5fb7\u5229<br \/>\n\u6d77\u5cb8<\/p>\n<p><u>\u5176\u4ed6\u65b0\u95fb<\/u><br \/>\n\u793c\u6765<br \/>\n\u7ebd\u91d1<br \/>\n\u661f\u836f\u4e1a<br \/>\n\u7ef4\u6258\u55b9\u8bfa\u5c14<\/p>\n<p>**********************************<br \/>\n\u516c\u53f8\u4e1a\u7ee9\u53d1\u5e03<\/p>\n<p>&gt; King Pharmaceuticals, Inc. \u516c\u5e03\u4e86\u622a\u81f3 2009 \u5e74 3 \u6708 31 \u65e5\u7684\u7b2c\u4e00\u5b63\u5ea6\u4e1a\u7ee9\u3002\u622a\u81f3 2009 \u5e74 3 \u6708 31 \u65e5\u7684\u7b2c\u4e00\u5b63\u5ea6\uff0cAlpharma \u52a8\u7269\u4fdd\u5065\u4e1a\u52a1\u7684\u6536\u5165\u4e3a $80 \u767e\u4e07\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09<\/p>\n<p>&gt; Bioniche Life Sciences Inc. \u5ba3\u5e03\u4e86\u622a\u81f3 2009 \u5e74 3 \u6708 31 \u65e5\u7684 2009 \u8d22\u5e74\u7b2c\u4e09\u5b63\u5ea6\u7684\u8d22\u52a1\u4e1a\u7ee9\u3002\u7efc\u5408\u6536\u5165\u603b\u8ba1 $740 \u4e07\u7f8e\u5143\uff0c\u800c 2008 \u8d22\u5e74\u540c\u671f\u4e3a $720 \u4e07\u7f8e\u5143\u3002\u9500\u552e\u989d\u7684\u589e\u957f\u6d89\u53ca\u591a\u79cd\u52a8\u7269\u4fdd\u5065\u4ea7\u54c1\u7ebf\uff0c\u5305\u62ec Folltropin-V\u3001Cue-mateTM\u3001Pregnecol \u548c\u80da\u80ce\u79fb\u690d\u4ea7\u54c1\uff0c\u8fd9\u4e9b\u4ea7\u54c1\u7684\u4fc3\u9500\u6d3b\u52a8\u4fc3\u8fdb\u4e86\u4f17\u591a\u5730\u533a\u7684\u9500\u552e\u989d\u589e\u957f\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09<\/p>\n<p>&gt; Provimi \u516c\u5e03\u4e86 2009 \u5e74\u7b2c\u4e00\u5b63\u5ea6\u7684\u4e1a\u7ee9\u3002\u6536\u5165\u4e3a 4.34 \u4ebf\u6b27\u5143\uff08$5.73 \u4ebf\uff09\uff0c\u4e0e 2008 \u5e74\u7b2c\u4e00\u5b63\u5ea6\u76f8\u6bd4\u4e0b\u964d\u4e86 19%\u3002\u9500\u552e\u989d\u4e0b\u964d\u4e3b\u8981\u5f52\u56e0\u4e8e\u539f\u6750\u6599\u4ef7\u683c\u4e0b\u964d\u548c\u9500\u91cf\u4e0b\u964d\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09<\/p>\n<p>&gt; Ridley, Inc. \u516c\u5e03\u4e86\u622a\u81f3 2009 \u5e74 3 \u6708 31 \u65e5\u7684 2009 \u8d22\u5e74\u7b2c\u4e09\u5b63\u5ea6\u4e1a\u7ee9\u3002\u6536\u5165\u4e3a $1.41 \u4ebf\u7f8e\u5143\uff0c\u4e0e\u53bb\u5e74\u540c\u671f\u76f8\u6bd4\u4e0b\u964d\u4e86 16%\u3002\u51c0\u6536\u5165\u4e3a $3.5 \u4ebf\u7f8e\u5143\uff0c\u800c\u53bb\u5e74\u540c\u671f\u4e3a $5.0 \u4ebf\u7f8e\u5143\u3002\u8425\u517b\u89e3\u51b3\u65b9\u6848\u90e8\u95e8\uff08\u5305\u62ec\u9972\u6599\u8865\u5145\u5242\u5757\u548c\u9a6c\u8425\u517b\u4e1a\u52a1\uff09\u62a5\u544a\u7684\u9500\u552e\u989d\u4e3a $31 \u4ebf\u7f8e\u5143\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09<\/p>\n<p>&gt; PetMed Express, Inc. \u516c\u5e03\u4e86\u622a\u81f3 2009 \u5e74 3 \u6708 31 \u65e5\u7684\u8d22\u5e74\u8d22\u52a1\u4e1a\u7ee9\u3002\u5168\u5e74\u51c0\u9500\u552e\u989d\u4e3a $2.19 \u4ebf\u7f8e\u5143\uff0c\u6bd4\u4e0a\u5e74\u589e\u957f 17%\u3002\u5168\u5e74\u51c0\u6536\u5165\u4e3a $23 \u4ebf\u7f8e\u5143\uff0c\u800c\u4e0a\u5e74\u7684\u51c0\u6536\u5165\u4e3a $20 \u4ebf\u7f8e\u5143\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09<\/p>\n<p>&gt; Seaboard Corp. \u62a5\u544a\u79f0\uff0c\u622a\u81f3 4 \u6708 4 \u65e5\u7684\u7b2c\u4e00\u5b63\u5ea6\u51c0\u5229\u6da6\u4e3a $16 \u767e\u4e07\uff0c\u800c\u53bb\u5e74\u540c\u671f\u7684\u51c0\u5229\u6da6\u4e3a $70 \u767e\u4e07\u3002\u672c\u5b63\u5ea6\u9500\u552e\u989d\u4e3a $917 \u4ebf\uff0c\u800c\u53bb\u5e74\u540c\u671f\u7684\u9500\u552e\u989d\u4e3a $994 \u4ebf\u3002\uff08Meating Place\uff09<\/p>\n<p>************************************<br \/>\n\u516c\u53f8\u65b0\u95fb\u7a3f<\/p>\n<p>&gt; Starpharma Holdings Limited \u5ba3\u5e03\u4e0e Elanco \u7b7e\u7f72\u5408\u4f5c\u7814\u7a76\u3001\u8bb8\u53ef\u548c\u5546\u4e1a\u5316\u534f\u8bae\u3002\u53cc\u65b9\u5c06\u5408\u4f5c\u5229\u7528 Starpharma \u7684\u6811\u679d\u72b6\u805a\u5408\u7269\u6280\u672f\u5f00\u53d1\u5177\u6709\u589e\u5f3a\u6027\u80fd\u7684\u65b0\u578b\u52a8\u7269\u4fdd\u5065\u4ea7\u54c1\u3002\uff08\u7f8e\u901a\u793e\uff09<\/p>\n<p>&gt; Vetoquinol USA \u5e86\u795d\u5176\u4f4d\u4e8e\u5fb7\u514b\u8428\u65af\u5dde\u6c83\u65af\u5821\u7684\u65b0\u7f8e\u56fd\u603b\u90e8\u5f00\u4e1a\u3002\u8fd9\u5bb6\u6cd5\u56fd\u516c\u53f8\u4e3e\u884c\u4e86\u526a\u5f69\u4eea\u5f0f\uff0c\u5176\u8463\u4e8b\u603b\u7ecf\u7406\u5728\u4eea\u5f0f\u4e0a\u5e26\u9886\u53c2\u89c2\u4e86\u5de5\u5382\u3002\uff08\u300a\u8fbe\u62c9\u65af\u5546\u4e1a\u6742\u5fd7\u300b\uff09<\/p>\n<p>&gt; Neogen \u5ba3\u5e03\u63a8\u51fa Funcol \u4f0a\u4e3d\u838e\u767d\u5708\uff0c\u8fd9\u662f\u4e00\u7cfb\u5217\u529f\u80fd\u9f50\u5168\u4e14\u8272\u5f69\u9c9c\u8273\u7684\u517d\u533b\u4f0a\u4e3d\u838e\u767d\u5708\u3002\u4e03\u79cd\u4e0d\u540c\u7684\u9879\u5708\u4e0a\u90fd\u6709\u722a\u5370\uff0c\u53ef\u8f7b\u677e\u8bc6\u522b\u8be5\u7cfb\u5217\u7684\u4e03\u79cd\u4e0d\u540c\u5c3a\u5bf8\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09<\/p>\n<p>************************************<br \/>\n\u52a8\u7269\u5065\u5eb7\u65b0\u95fb<\/p>\n<p>&gt; \u58a8\u897f\u54e5 \u2014 H1N1 \u75c5\u6bd2 \u53f2\u5bc6\u65af\u83f2\u5c14\u5fb7\u98df\u54c1\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98\u5728\u81f4\u5458\u5de5\u7684\u4e00\u5c01\u4fe1\u4e2d\u8868\u793a\uff0c\u58a8\u897f\u54e5\u653f\u5e9c\u5bf9\u8be5\u516c\u53f8\u5728\u97e6\u62c9\u514b\u9c81\u65af\u5dde\u7684\u732a\u7fa4\u8fdb\u884c\u7684\u989d\u5916\u68c0\u6d4b\u7ed3\u679c\u663e\u793a\u672a\u53d1\u73b0 H1N1 \u6216\u4efb\u4f55\u5176\u4ed6\u75c5\u6bd2\uff0c\u8fd9\u4e0e\u5f53\u5730\u5173\u4e8e\u8be5\u519c\u573a\u662f\u75ab\u60c5\u6e90\u5934\u7684\u6307\u63a7\u76f8\u77db\u76fe\u3002\u5373\u4f7f\u5728\u58a8\u897f\u54e5\u3001\u7f8e\u56fd\u548c\u5176\u4ed6\u56fd\u9645\u536b\u751f\u5f53\u5c40\u68c0\u67e5\u4e86\u8be5\u516c\u53f8\u5728\u97e6\u62c9\u514b\u9c81\u65af\u5dde\u7684\u8054\u5408\u519c\u573a\u5e76\u786e\u5b9a\u6ca1\u6709\u8bc1\u636e\u8868\u660e H1N1 \u6e90\u81ea\u8be5\u519c\u573a\u540e\uff0c\u53f2\u5bc6\u65af\u83f2\u5c14\u5fb7\u4ecd\u4e3b\u52a8\u5bfb\u6c42\u72ec\u7acb\u5b9e\u9a8c\u5ba4\u7684\u68c0\u6d4b\u670d\u52a1\u3002\uff08Meating Place\uff09<\/p>\n<p>&gt; \u7f8e\u56fd\u3001\u6b27\u76df \u2014 \u6fc0\u7d20\u725b\u8089 \u7f8e\u56fd\u6700\u9ad8\u8d38\u6613\u4ee3\u8868\u8868\u793a\uff0c\u7f8e\u56fd\u548c\u6b27\u76df\u4e4b\u95f4\u56e0\u6fc0\u7d20\u725b\u8089\u800c\u957f\u671f\u5b58\u5728\u7684\u8d38\u6613\u51b2\u7a81\u5df2\u57fa\u672c\u89e3\u51b3\u3002\u6b27\u76df\u4e0a\u5468\u540c\u610f\u8d2d\u4e70\u66f4\u591a\u9ad8\u4ef7\u503c\u7f8e\u56fd\u725b\u8089\uff0c\u4ee5\u907f\u514d\u610f\u5927\u5229\u77ff\u6cc9\u6c34\u548c\u6cd5\u56fd\u6d1b\u514b\u798f\u5976\u916a\u7b49\u7ecf\u5178\u6b27\u6d32\u4ea7\u54c1\u53d7\u5230\u7f8e\u56fd\u5236\u88c1\u3002\u7f8e\u56fd\u79f0\uff0c\u4e16\u754c\u8d38\u6613\u7ec4\u7ec7\u5728\u8fd9\u573a\u6301\u7eed 13 \u5e74\u7684\u4e89\u7aef\u4e2d\u591a\u6b21\u505a\u51fa\u6709\u5229\u4e8e\u6b27\u76df\u7684\u88c1\u51b3\u3002\uff08Cattle Network\uff09<\/p>\n<p>&gt; \u7f8e\u56fd \u2013 \u52a8\u7269\u7acb\u6cd5 \u7f05\u56e0\u5dde\u5dde\u957f\u7b7e\u7f72\u7acb\u6cd5\uff0c\u7981\u6b62\u4e24\u79cd\u519c\u573a\u52a8\u7269\u9972\u517b\u65b9\u6cd5\u3002\u65b0\u6cd5\u5f8b\u5c06\u4e8e 2011 \u5e74 1 \u6708 1 \u65e5\u751f\u6548\uff0c\u7981\u6b62\u4f7f\u7528\u598a\u5a20\u7bb1\u548c\u5c0f\u725b\u8089\u7bb1\u3002\uff08Feedstuffs\uff09<\/p>\n<p>************************************<br \/>\nBRAKKE \u54a8\u8be2\u89c2\u70b9<\/p>\n<p>\u6ca1\u6709\u4ec0\u4e48\u6bd4\u5728\u534e\u76db\u987f\u7279\u533a\u5f85\u51e0\u5929\u66f4\u80fd\u8ba9\u4eba\u66f4\u597d\u5730\u7406\u89e3\u4e3a\u4ec0\u4e48 4 \u6708 15 \u65e5\u5bf9\u6211\u4eec\u7684\u8054\u90a6\u653f\u5e9c\u5982\u6b64\u91cd\u8981\u3002\u95ee\u9898\u4f3c\u4e4e\u662f\u56fd\u4f1a\u76d1\u7763\u4e0b\u7684\u653f\u5e9c\u673a\u6784\u82b1\u94b1\u7684\u901f\u5ea6\u6bd4\u6211\u4eec\u7ed9\u4ed6\u4eec\u94b1\u7684\u901f\u5ea6\u5feb\u3002<\/p>\n<p>\u6211\u5fc5\u987b\u8bf4\uff0c\u6211\u786e\u5b9e\u5f88\u4eab\u53d7\u5728\u534e\u76db\u987f\u7684\u65f6\u5149\uff0c\u62dc\u8bbf\u4e86 CVM\uff08\u517d\u533b\u4e2d\u5fc3\uff09\u7684\u7ba1\u7406\u5c42\u3001\u51e0\u4f4d\u5ba2\u6237\uff0c\u5e76\u53c2\u52a0\u4e86\u52a8\u7269\u519c\u4e1a\u8054\u76df\u4f1a\u8bae\u3002\u6211\u5bf9\u52a8\u7269\u519c\u4e1a\u8054\u76df\u8fc7\u53bb\u51e0\u5e74\u53d6\u5f97\u7684\u8fdb\u5c55\u5370\u8c61\u7279\u522b\u6df1\u523b\u3002\u51fa\u5e2d\u4f1a\u8bae\u7684\u6709 150 \u591a\u540d\u7ba1\u7406\u4eba\u5458\uff0c\u4ed6\u4eec\u4ee3\u8868\u4e86\u4e3b\u8981\u7269\u79cd\u7684\u56fd\u5bb6\u548c\u5dde\u7ec4\u7ec7\u3001\u4ea7\u54c1\u5236\u9020\u5546\u548c\u5176\u4ed6\u652f\u6301\u52a8\u7269\u519c\u4e1a\u7684\u4eba\u58eb\u3002\u5728\u6211\u770b\u6765\uff0c\u52a8\u7269\u519c\u4e1a\u8054\u76df\u62e5\u6709\u5408\u9002\u7684\u4eba\u9009\uff0c\u5982\u679c\u76f8\u5173\u4eba\u5458\u7684\u5171\u540c\u5229\u76ca\u80fd\u591f\u96c6\u4e2d\u5728\u4f18\u5148\u95ee\u9898\u4e0a\uff0c\u90a3\u4e48\u5728\u6253\u51fb\u5404\u79cd\u53cd\u52a8\u7269\u519c\u4e1a\u56e2\u4f53\u4f20\u64ad\u7684\u4fe1\u606f\u65b9\u9762\uff0c\u96a7\u9053\u5c3d\u5934\u53ef\u80fd\u4f1a\u51fa\u73b0\u66d9\u5149\u3002<\/p>\n<p>\u9700\u8981\u5171\u540c\u52aa\u529b\u6765\u6559\u80b2\u516c\u4f17\u6709\u5173\u755c\u7267\u4e1a\u7684\u77e5\u8bc6\uff0c\u5e76\u6d88\u9664\u6d88\u8d39\u8005\u5fc3\u4e2d\u666e\u904d\u5b58\u5728\u7684\u9519\u8bef\u4fe1\u606f\u5ba3\u4f20\u3002\u636e\u4f30\u8ba1\uff0c2007 \u5e74\u548c 2008 \u5e74\uff0c\u52a8\u7269\u6743\u5229\u6216\u798f\u5229\u7ec4\u7ec7\u6bcf\u5e74\u7b79\u96c6\u7684\u8d44\u91d1\u8d85\u8fc7 14 \u4ebf\u7f8e\u5143\u3002\u9996\u5148\uff0c\u5728\u8fc7\u53bb 30 \u5929\u5185\uff0c\u60a8\u662f\u5426\u5c31\u755c\u7267\u4e1a\u95ee\u9898\u7ed9\u5dde\u6216\u56fd\u5bb6\u4ee3\u8868\u6253\u8fc7\u7535\u8bdd\u6216\u5199\u8fc7\u4fe1\uff1f\u5982\u679c\u6ca1\u6709\uff0c\u90a3\u4e48\u60a8\u5c31\u662f\u95ee\u9898\u7684\u4e00\u90e8\u5206\uff1b\u4ed6\u4eec\u9700\u8981\u542c\u542c\u90a3\u4e9b\u4e86\u89e3\u6545\u4e8b\u53e6\u4e00\u9762\u7684\u4eba\u7684\u610f\u89c1\u3002<\/p>\n<p>\u795d\u5468\u672b\u6109\u5feb\uff01<\/p>\n<p>\u7f57\u6069\u00b7\u5e03\u62c9\u514b<\/p>\n<p>************************************<br \/>\n\u672c\u7535\u5b50\u901a\u8baf\u5f52 Brakke Consulting, Inc. \u72ec\u6709\u3002<br \/>\n\u5bf9\u672c\u6587\u5185\u5bb9\u7684\u4efb\u4f55\u4f7f\u7528\u5747\u987b\u7ecf\u8fc7 Brakke Consulting, Inc. \u7684\u6279\u51c6\u5e76\u9002\u5f53\u6ce8\u660e\u6765\u6e90\u3002<br \/>\n\u6709\u5173 Brakke Consulting \u670d\u52a1\u548c\u8054\u5408\u7814\u7a76\u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9 <a href=\"https:\/\/brakkeconsulting.com\/zh\/\">www.brakkeconsulting.com<\/a>.<\/p>\n<p>Brakke \u54a8\u8be2\u516c\u53f8<br \/>\n2735 Villa Creek\uff0c\u5957\u623f 140<br \/>\n\u7f8e\u56fd\u5fb7\u514b\u8428\u65af\u5dde\u8fbe\u62c9\u65af 75234<\/p>","protected":false},"excerpt":{"rendered":"<p>\u6253\u5370\u7248\u672c ************************************ Brakke Consulting 2009 \u5e74 5 \u6708 15 \u65e5\u7684\u52a8\u7269\u4fdd\u5065\u65b0\u95fb\u548c\u7b14\u8bb0 \u7248\u6743\u6240\u6709 \u00a9 Brakke Consulting, Inc. \u7f16\u8f91\uff1aLynn Fondon, DVM, MBA ************************************ \u65b0\u95fb\uff1a \u6536\u76ca\u65b0\u95fb Alpharma Bioniche PetMed Express Provimi Ridley Seaboard \u5176\u4ed6\u65b0\u95fb Elanco Neogen Starpharma Vetoquinol ********************************** \u516c\u53f8\u6536\u76ca\u62a5\u544a &gt; King Pharmaceuticals, Inc. \u5ba3\u5e03\u4e86\u622a\u81f3 2009 \u5e74 3 \u6708 31 \u65e5\u7684\u7b2c\u4e00\u5b63\u5ea6\u4e1a\u7ee9\u3002\u622a\u81f3 2009 \u5e74 3 \u6708 31 \u65e5\u7684\u7b2c\u4e00\u5b63\u5ea6\uff0cAlpharma \u52a8\u7269\u4fdd\u5065\u4e1a\u52a1\u7684\u6536\u5165\u4e3a $80 \u767e\u4e07\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09 &gt; Bioniche Life Sciences Inc. \u5ba3\u5e03\u4e86\u622a\u81f3 2009 \u5e74 3 \u6708 31 \u65e5\u7684 2009 \u8d22\u5e74\u7b2c\u4e09\u5b63\u5ea6\u7684\u8d22\u52a1\u7ed3\u679c\u3002 2008 \u8d22\u5e74\u540c\u671f\u4e3a $720 \u4e07\u7f8e\u5143\u3002\u9500\u552e\u989d\u7684\u589e\u957f\u6d89\u53ca\u591a\u79cd\u52a8\u7269\u4fdd\u5065\u4ea7\u54c1\u7ebf\uff0c\u5305\u62ec Folltropin-V\u3001Cue-mateTM\u3001Pregnecol \u548c\u80da\u80ce\u79fb\u690d\u4ea7\u54c1\uff0c\u8fd9\u4e9b\u4ea7\u54c1\u7684\u4fc3\u9500\u6d3b\u52a8\u4fc3\u8fdb\u4e86\u591a\u4e2a\u5730\u533a\u7684\u9500\u552e\u989d\u589e\u957f\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09&gt; Provimi \u516c\u5e03\u4e86 2009 \u5e74\u7b2c\u4e00\u5b63\u5ea6\u7684\u4e1a\u7ee9\u3002\u6536\u5165\u4e3a 4.34 \u4ebf\u6b27\u5143\uff08$5.73 \u4ebf\u6b27\u5143\uff09\uff0c\u4e0e 2008 \u5e74\u7b2c\u4e00\u5b63\u5ea6\u76f8\u6bd4\u4e0b\u964d\u4e86 19%\u3002\u9500\u552e\u989d\u4e0b\u964d\u4e3b\u8981\u5f52\u56e0\u4e8e\u539f\u6750\u6599\u4ef7\u683c\u4e0b\u8dcc\u548c\u9500\u91cf\u4e0b\u964d\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&gt; Ridley, Inc. \u516c\u5e03\u4e86\u622a\u81f3 2009 \u5e74 3 \u6708 31 \u65e5\u7684 2009 \u8d22\u5e74\u7b2c\u4e09\u5b63\u5ea6\u7684\u4e1a\u7ee9\u3002\u6536\u5165\u4e3a $1.41 \u4ebf\u6b27\u5143\uff0c\u4e0b\u964d\u4e86 16%<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/306\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-306","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/306\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version ************************************ Brakke Consulting&#8217;s Animal Health News &amp; Notes for May 15, 2009 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: earnings news Alpharma Bioniche PetMed Express Provimi Ridley Seaboard other news Elanco Neogen Starpharma Vetoquinol ********************************** COMPANY EARNINGS RELEASES &gt; King Pharmaceuticals, Inc. announced results for the first quarter ended March 31, 2009. Revenues from the Alpharma Animal Health business were $80 million for the first quarter ended March 31, 2009. (company website) &gt; Bioniche Life Sciences Inc. announced financial results for the third quarter of its 2009 fiscal year, ending March 31, 2009. Consolidated revenues totaled $7.4 million compared to $7.2 million for the corresponding period in fiscal 2008. The increase in sales involved a variety of animal health product lines, including Folltropin-V, Cue-mateTM, Pregnecol and embryo transfer products where promotional efforts contributed to increased sales across numerous geographic locations. (company website) &gt; Provimi reported results for the first quarter of 2009.\u00a0 Revenues were EUR 434 million ($573 million), a decline of 19% compared to the first quarter of 2008.\u00a0 The sales decrease was primarily attributable to decreasing raw material prices and lower volumes. (company press release) &gt; Ridley, Inc. reported results for its fiscal 2009 third quarter ended March 31, 2009.\u00a0 Revenues were $141 million, a decline of 16%View Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/306\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2009-05-15T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-16T18:39:08+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/306\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/306\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for May 15, 2009\",\"datePublished\":\"2009-05-15T17:51:17+00:00\",\"dateModified\":\"2018-04-16T18:39:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/306\/\"},\"wordCount\":984,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/306\/\",\"url\":\"https:\/\/brakkeconsulting.com\/306\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#website\"},\"datePublished\":\"2009-05-15T17:51:17+00:00\",\"dateModified\":\"2018-04-16T18:39:08+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/306\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/306\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/306\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/ja\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for May 15, 2009\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/ja\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/306\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version ************************************ Brakke Consulting&#8217;s Animal Health News &amp; Notes for May 15, 2009 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: earnings news Alpharma Bioniche PetMed Express Provimi Ridley Seaboard other news Elanco Neogen Starpharma Vetoquinol ********************************** COMPANY EARNINGS RELEASES &gt; King Pharmaceuticals, Inc. announced results for the first quarter ended March 31, 2009. Revenues from the Alpharma Animal Health business were $80 million for the first quarter ended March 31, 2009. (company website) &gt; Bioniche Life Sciences Inc. announced financial results for the third quarter of its 2009 fiscal year, ending March 31, 2009. Consolidated revenues totaled $7.4 million compared to $7.2 million for the corresponding period in fiscal 2008. The increase in sales involved a variety of animal health product lines, including Folltropin-V, Cue-mateTM, Pregnecol and embryo transfer products where promotional efforts contributed to increased sales across numerous geographic locations. (company website) &gt; Provimi reported results for the first quarter of 2009.\u00a0 Revenues were EUR 434 million ($573 million), a decline of 19% compared to the first quarter of 2008.\u00a0 The sales decrease was primarily attributable to decreasing raw material prices and lower volumes. (company press release) &gt; Ridley, Inc. reported results for its fiscal 2009 third quarter ended March 31, 2009.\u00a0 Revenues were $141 million, a decline of 16%View Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/306\/","og_site_name":"Brakke Consulting Website","article_published_time":"2009-05-15T17:51:17+00:00","article_modified_time":"2018-04-16T18:39:08+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Brakke Consulting","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"5 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/306\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/306\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for May 15, 2009","datePublished":"2009-05-15T17:51:17+00:00","dateModified":"2018-04-16T18:39:08+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/306\/"},"wordCount":984,"articleSection":["Newsletter"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/306\/","url":"https:\/\/brakkeconsulting.com\/306\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/ja\/#website"},"datePublished":"2009-05-15T17:51:17+00:00","dateModified":"2018-04-16T18:39:08+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/306\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/306\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/306\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/ja\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for May 15, 2009"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/ja\/#website","url":"https:\/\/brakkeconsulting.com\/ja\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/ja\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"\u5e03\u62c9\u514b\u54a8\u8be2\u516c\u53f8","url":"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/306","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=306"}],"version-history":[{"count":2,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/306\/revisions"}],"predecessor-version":[{"id":25614,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/306\/revisions\/25614"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=306"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=306"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}